Quantitative analysis shows ESG integration influences pricing in European real estate, suggesting investor preferences can enhance market valuation.
The pricing of European listed real estate increasingly reflects the dual influence of traditional financial metrics and non-financial considerations, particularly environmental, social, and governance (ESG) integration. This study develops a conceptual framework linking investor preferences with ESG transparency to explain variations in pricing efficiency within the sector. The framework highlights how growing institutional demand for sustainable assets interacts with disclosure practices and governance structures, shaping capital allocation and market valuation. The research problem addressed is the limited empirical clarity on how ESG integration affects pricing in real estate securities, particularly when compared with conventional determinants such as leverage, dividend policy, and asset quality. Methodologically, the study employs a quantitative framework analysis using panel data from European REITs and listed property firms, incorporating ESG ratings, financial performance indicators, and investor sentiment proxies. The results demonstrate that stronger ESG integration is associated with reduced cost of capital and narrower deviations from intrinsic value, while investor preferences for sustainability-oriented assets amplify this effect across markets. Furthermore, evidence suggests that the pricing premium for ESG-compliant firms is more pronounced in jurisdictions with stricter disclosure regulations. The implications are twofold: theoretically, the study advances understanding of sustainable finance by situating ESG integration within asset pricing theory; practically, it offers guidance for investors, policymakers, and managers in aligning real estate markets with long-term environmental and social objectives. Keywords Investor preferences, ESG integration, European real estate, listed property firms, REITs, asset pricing, sustainable finance, disclosure transparency, cost of capital, market valuation
No takes yet. Share an insight, caveat, or question.
Murali Krishna Pasupuleti (2024) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: